Search results for " costs"
Article
Reducing Cross-Contamination Risks in Process Chromatography
Reducing Cross-Contamination Risks in Process Chromatography
Single-use systems provide replaceable fluid paths.
By Cynthia A. Challener
…
Article
Improving Process-Scale Chromatography
Advances in technology are increasing the productivity and efficiency of commercial-scale chromatography bioprocesses.
By Cynthia Challener, PhD
Chromatography is a crucial step in the purif…
Article
Platform Approach Speeds Process Development
Minimal early development effort, however, may induce increased challenges in late-stage process development that may result in unnecessary costs and delays.
For comprehensive process development, i…
Article
Tools for Continuous Bioprocessing Development
Because typical perfusion process experiments consume 1–3 working volumes per day and can run for 20–60 days, culture media costs alone contribute to prohibitively expensive experimental campaigns. Fo…
Article
Changing the Culture of Cell Culture: Applying Best Practices and Authentication to Ensure Scientific Reproducibility
Neve
Irreproducible preclinical research is a global, expensive, and well-recognized problem that contributes to delays and increased costs of drug discovery (1, 2). One published study conservati…
Article
EMA Collaborates with HTA Assessment Networks
The Impact of HTAs on Biosimilars
As a result of cuts in healthcare costs due to post-recession austerity programs, favorable HTAs are becoming crucial to the successful market launch of pharmace…
Article
HT Multi-Product Liquid Chromatography for Characterization of Monoclonal Antibodies
By taking a holistic approach to improving the analytical process, one can identify strategies to increase throughput and reduce development times and the costs of analytical methods. This article dis…
Article
Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
By using modern techniques and cell-based upstream processes it is possible to produce closer to the local market in order to overcome distribution hurdles, as well as to bring down production costs a…
Article
The Future of Biopharma
Innovation speeds discovery, drives down costs, and improves productivity. The current situation in the biopharmaceutical industry is exciting enough, with biosimilars, new technologies, personalized …
Article
New Therapies Present Scaling Challenges
Lowering the costs associated with commercial-scale autologous cell-therapy manufacture therefore relies on advanced engineering solutions and innovative manufacturing technologies that reduce the com…